CorVel (CRVL) AI Stock Analysis

• Market Cap: $3.80B
• Dividend Yield: N/A
• Average Volume (3M): 195.94K
• Price to Earnings (P/E): 37.8
• Beta (1Y): 0.79
• Revenue Growth: 12.46%
• EPS Growth: 29.16%
• Country: US
• Employees: 4,870
• Sector: Financial
• Sector Strength: 70
• Industry: Insurance - Brokers
• EPS (TTM): 0.53
• Shares Outstanding: 51,312,748
• 10 Day Avg. Volume: 156,298
• 30 Day Avg. Volume: 195,943
• PEG Ratio: 2.42
• Price to Book (P/B): 17.87
• Price to Sales (P/S): 6.42
• P/FCF Ratio: 62.84
• Enterprise Value/Market Cap: 1.36
• Enterprise Value/Revenue: 5.62
• Enterprise Value/Gross Profit: 23.64
• Enterprise Value/Ebitda: 32.57
• 1Y Price Target: $77.00
• Price Target Upside: 4.95% Upside
• Rating Consensus: Hold
• Number of Analyst Covering: 1

• Rating: 60 Neutral
• Price Target: $77.00 ▲(4.95% Upside)

CorVel's strong financial performance is a key strength, supported by consistent growth and solid financial management. However, bearish technical indicators and a high valuation relative to earnings limit the stock's attractiveness. The absence of earnings call insights and corporate events further emphasizes reliance on existing financial and technical data.

CorVel Business Overview & Revenue Model

Company Description

CorVel Corporation provides workers' compensation, auto, liability, and health solutions for employers, third party administrators, insurance companies, and government agencies to assist them in managing the medical costs and monitoring the quality of care associated with healthcare claims. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company offers network solutions services, including automated medical fee auditing, preferred provider management and reimbursement services, retrospective utilization review, facility claim review, professional review, pharmacy services, directed care services, Medicare solutions, clearinghouse services, independent medical examinations, and inpatient medical bill review. It also provides a range of patient management services, such as claims management, case management, 24/7 nurse triage, utilization management, vocational rehabilitation, and life care planning, as well as processing of claims for self-insured payors with respect to property and casualty insurance. The company was incorporated in 1987 and is headquartered in Fort Worth, Texas.

How the Company Makes Money

CorVel generates revenue through a diversified model that includes fees for its various services. Key revenue streams comprise the management of workers' compensation claims, which includes medical and non-medical cost containment services, and the provision of pharmacy benefit management services. The company also earns income from its advanced data analytics and technology solutions that assist clients in making informed decisions regarding risk management. Significant partnerships with insurance companies, third-party administrators, and self-insured employers enhance CorVel's ability to capture a larger market share and drive revenue growth. Additionally, the company benefits from economies of scale as it expands its client base, allowing it to optimize operational efficiencies and increase profitability.

CorVel Financial Statement Overview

Summary

CorVel Corporation exhibits robust financial health with strong revenue and profit growth, efficient leverage management, and solid cash flow generation. Minor fluctuations in operational efficiency and free cash flow growth warrant monitoring, but the overall financial trajectory is positive.

Income Statement

CorVel has shown a strong upward trajectory in revenue growth, with revenue increasing consistently over the past years. The company's gross profit and net profit margins are healthy, demonstrating effective cost management and profitability. However, the slight fluctuation in EBIT and EBITDA margins suggests potential volatility in operational efficiency.

Balance Sheet

CorVel maintains a robust financial position with a very low debt-to-equity ratio, indicating prudent leverage management. The company has a strong equity ratio, suggesting financial stability and a solid asset base. High return on equity further emphasizes the company's efficiency in generating returns for shareholders.

Cash Flow

The company has demonstrated strong free cash flow generation and growth, supported by consistent operating cash flows. The operating cash flow to net income ratio indicates effective conversion of income into cash, though minor fluctuations in free cash flow growth suggest potential investment or expenditure variations.

Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	918.58M	895.59M	795.31M	718.56M	646.23M	552.64M
Gross Profit	218.33M	209.73M	171.69M	158.26M	152.11M	123.62M
EBITDA	158.47M	150.36M	121.35M	109.67M	108.43M	82.61M
Net Income	100.82M	95.17M	76.25M	66.36M	66.41M	46.36M
Balance Sheet
Total Assets	597.45M	545.98M	454.68M	393.92M	415.25M	424.76M
Cash, Cash Equivalents and Short-Term Investments	202.03M	170.58M	105.56M	71.33M	97.50M	139.72M
Total Debt	27.42M	28.08M	31.40M	33.76M	43.14M	54.66M
Total Liabilities	254.92M	223.99M	207.03M	191.75M	202.85M	204.36M
Stockholders Equity	342.53M	321.99M	247.65M	202.18M	212.40M	220.40M
Cash Flow
Free Cash Flow	98.34M	91.56M	70.00M	55.97M	37.40M	77.14M
Operating Cash Flow	141.89M	127.31M	99.24M	82.29M	67.22M	94.38M
Investing Cash Flow	-43.55M	-35.76M	-29.24M	-26.32M	-29.82M	-17.24M
Financing Cash Flow	-28.23M	-26.54M	-35.76M	-82.14M	-79.61M	-20.64M

CorVel Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 73.37
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Positive
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CRVL, the sentiment is Negative. The current price of 73.37 is below the 20-day moving average (MA) of 78.78, below the 50-day MA of 84.54, and below the 200-day MA of 102.95, indicating a bearish trend. The MACD of -3.56 indicates Positive momentum. The RSI at 28.16 is Positive, neither overbought nor oversold. The STOCH value of 23.78 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for CRVL.

CorVel Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
BRO	76 Outperform	$31.15B	27.23	11.27%	0.63%	11.68%	-0.17%
CRD.A	69 Neutral	$494.99M	17.18	18.06%	2.78%	5.58%	28.75%
Sector *	68 Neutral	$18.00B	11.42	9.92%	3.81%	9.73%	1.22%
TWFG	66 Neutral	$1.58B	67.82	8.26%	―	17.86%	-77.16%
CRD.B	62 Neutral	$494.99M	16.10	18.06%	2.88%	5.58%	28.75%
CRVL	60 Neutral	$3.80B	37.83	33.25%	―	12.46%	29.16%
BWIN	45 Neutral	$3.28B	―	-2.91%	―	11.43%	64.61%

CorVel Corporate Events

CorVel Holds 2025 Annual Stockholders Meeting

On August 7, 2025, CorVel Corporation held its 2025 Annual Meeting of Stockholders, where shareholders voted on three key proposals. The election of six directors to serve until the 2026 meeting was conducted, with varying levels of support for each candidate. Additionally, the appointment of Haskell & White LLP as the independent registered public accounting firm for the fiscal year ending March 31, 2026, was ratified. Lastly, the 2025 Stock Incentive Plan was approved, indicating continued strategic focus on incentivizing performance and aligning interests with shareholders.